The adaptor Act1 is required for interleukin 17 - Dependent signaling associated with autoimmune and inflammatory disease

Nature Immunology

Volumn 8, Issue 3, 2007, Pages 247-256

  Qian, Youcun ^a   Liu, Caini ^a   Hartupee, Justin ^a   Altuntas, Cengiz Zubeyir ^a   Gulen, Muhammet Fatih ^a   Jane Wit, Daniel ^a   Xiao, Jianhua ^a   Lu, Yi ^a   Giltiay, Natalia ^a   Liu, Jinbo ^b   Kordula, Tomasz ^c   Zhang, Qi Wei ^a   Vallance, Bruce ^d   Swaidani, Shadi ^a   Aronica, Mark ^a   Tuohy, Vincent K ^a   Hamilton, Thomas ^a   Li, Xiaoxia ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

^c VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^d UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTOR PROTEIN; DEXTRAN SULFATE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 17; PROTEIN ACT1; TRANSFORMING GROWTH FACTOR BETA ACTIVATED KINASE 1; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG; B CELL ACTIVATING FACTOR RECEPTOR; C6ORF4 PROTEIN, HUMAN; CD40 ANTIGEN; IL17R PROTEIN, HUMAN; INTERLEUKIN 17 RECEPTOR; SIGNAL TRANSDUCING ADAPTOR PROTEIN;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNE DISEASE; COLITIS; CONTROLLED STUDY; CYTOPLASM; DOWNSTREAM PROCESSING; EMBRYO; EPITHELIUM CELL; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOSTIMULATION; IN VIVO STUDY; INFLAMMATORY DISEASE; MACROGLIA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION; ADOPTIVE TRANSFER; ANIMAL; AUTOIMMUNITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; HELA CELL; IMMUNOLOGY; INFLAMMATION; METABOLISM; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADOPTIVE TRANSFER; ANIMALS; ANTIGENS, CD40; AUTOIMMUNE DISEASES; AUTOIMMUNITY; B-CELL ACTIVATION FACTOR RECEPTOR; COLITIS; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION; GENE EXPRESSION REGULATION; HELA CELLS; HUMANS; INFLAMMATION; INTERLEUKIN-17; MICE; RECEPTORS, INTERLEUKIN-17; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; T-LYMPHOCYTES; TRANSFECTION;

EID: 34247873196     PISSN: 15292908     EISSN: 15292916     Source Type: Journal    
DOI: 10.1038/ni1439     Document Type: Article

References (55)

1. Kolls, J.K. & Linden, A. Interleukin-17 family members and inflammation. Immunity 21, 467-476 (2004).
2. Veldhoen, M., Hocking, R.J., Atkins, C.I., Locksley, R.M. & Stockinger, B. TGFβ in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 24 179-189 (2006).
3. H17 lineage. Nature 441, 231-234 (2006).
4. + effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat. Immunol. 6, 1123-1132 (2005).
5. Park, H. et al. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interieukin 17. Nat. Immunol. 6, 1133-1141 (2005).
6. H17 and regulatory T cells. Nature 441, 235-238 (2006).
7. H17 lineage. Nature 441, 231-234 (2006).
8. B. Nakae, S. et al. Antigen-specific T cell sensitization is impaired in IL-17-deficient mice, causing suppression of allergic cellular and humoral responses. Immunity 17, 375-387 (2002).
9. Iwakura, Y. & Ishigame, H. The IL-23/IL-17 axis in inflammation. J. Clin. Invest. 116, 1218-1222 (2006).
10. Kolls, J.K. & Linden, A. Interleukin-17 family members and inflammation. Immunity 21, 467-476 (2004).
11. Toy, D. et al. Cutting Edge: Interleukin 17 signals through a heteromeric receptor complex. J. Immunol. 177, 36-39 (2006).
12. Trajkovic, V. et al. Interleukin-17 stimulates inducible nitric oxide synthase activation in rodent astrocytes. J. Neuroimmunol. 119, 183-191 (2001).
13. Inoue, D. et al. IL-17A promotes the growth of airway epithelial cells through ERK-dependent signaling pathway. Biochem. Biophys. Res. Commun. 347, 852-858 (2006).
14. Novatchkova, M., Leibbrandt, A., Werzowa, J., Neubuser, A. & Eisenhaber, F. The STIR-domain superfamily in signal transduction, development and immunity. Trends Biochem. Sci. 28, 226-229 (2003).
15. Yao, Z. et al. Molecular characterization of the human interleukin (IL)-17 receptor. Cytokine 9, 794-800 (1997).
16. Schwandner, R., Yamaguchi, K. & Cao, Z. Requirement of tumor necrosis factor receptor-associated factor (TRAF)6 in interleukin 17 signal transduction. J. Exp. Med. 191, 1233-1240 (2000).
17. Li, X. et al. Act1, an NF-κB-activating protein. Proc. Natl. Acad. Sci. USA 97, 10489-10493 (2000).
18. Leonardi, A., Chariot, A., Claudio, E., Cunningham, K. & Siebenlist, U. CIKS, a connection to IκB kinase and stress-activated protein kinase. Proc. Natl. Acad. Sci. USA 97, 10494-10499 (2000).
19. Qian, Y., Zhao, Z., Jiang, Z. & Li, X. Role of NFκB activator Act1 in CD40-mediated signaling in epithelial cells. Proc. Natl. Acad. Sci. USA 99, 9386-9391 (2002).
20. Qian, Y. et al. Act1, a negative regulator in CD40- and BAFF-mediated B cell survival. Immunity 21, 575-587 (2004).
21. Novatchkova, M., Leibbrandt, A., Werzowa, J., Neubuser, A. & Eisenhaber, F. The STIR-domain superfamily in signal transduction, development and immunity. Trends Biochem. Sci. 28, 226-229 (2003).
22. Cua, D.J. et al. Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature 421, 744-748 (2003).
23. Chen, Y. et al. Anti-IL-23 therapy inhibits multiple inflammatory pathways and ameliorates autoimmune encephalomyelitis. J. Clin. Invest. 116, 1317-1326 (2006).
24. Park, H. et al. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat. Immunol. 6, 1133-1141 (2005).
25. Chen, Y. et al. Stimulation of airway mucin gene expression by interleukin (IL)-17 through IL-6 paracrine/autocrine loop. J. Biol. Chem. 278, 17036-17043 (2003).
26. Awane, M., Andres, P.G., Li, D.J. & Reinecker, H.C. NF-κB-inducing kinase is a common mediator of IL-17, TNF-α-, and IL-1β-induced chemokine promoter activation in intestinal epithelial cells. J. Immunol. 162, 5337-5344 (1999).
27. Ruddy, M.J. et al. Functional cooperation between interleukin-17 and tumor necrosis factor-α is mediated by CCAAT/enhancer-binding protein family members. J. Biol. Chem. 279, 2559-2567 (2004).
28. Weaver, A. et al. An elevated matrix metalloproteinase (MMP) in an animal model of multiple sclerosis is protective by affecting Th1/Th2 polarization. FASEB J. 19, 1668-1670 (2005).
29. Becher, B., Bechmann, I. & Greter, M. Antigen presentation in autoimmunity and CNS inflammation: How T lymphocytes recognize the brain. J. Mol. Med. 84, 532-543 (2006).
30. Gold, R., Linington, C. & Lassmann, H. Understanding pathogenesis and therapy of multiple sclerosis via animal models: 70 years of merits and culprits in experimental autoimmune encephalomyelitis research. Brain 129, 1953-1971 (2006).
31. Koenders, M.I. et al. Interleukin-17 receptor deficiency results in impaired synovial pression of interieukin-1 and matrix metalloprateinases 3, 9, and 13 and prevents cartilage destruction during chronic reactivated streptococcal cell wall-induced arthritis. Arthritis Rheum. 52, 3239-3247 (2005).
32. Dong, Y. & Benveniste, E.N. Immune function of astrocytes. Glia 36, 180-190 (2001).
33. Iwakura, Y. & Ishigame, H. The IL-23/IL-17 axis in inflammation. J. Clin. Invest. 116, 1218-1222 (2006).
34. Zhang, Z., Zheng, M., Bindas, J., Schwarzenberger, P. & Kolls, J.K. Critical role of IL-17 receptor signaling in acute TNBS-incluced colitis. Inflamm. Bowel Dis. 12, 382-388 (2006).
35. Zhao, Z. et al. IFN regulatory factor-1 is required for the up-regulation of the CD40-NFκB activator 1 axis during airway inflammation. J. Immunol. 170, 5674-5680 (2003).
36. Schwartz, S., Beaulieu, J.F. & Ruemmele, F.M. Interleukin-17 is a potent immuno-modulator and regulator of normal human intestinal epithelial cell growth. Biochem. Biophys. Res. Commun. 337, 505-509 (2005).
37. Wen, F. et al. Expression of conditional cre recombinase in epithelial tissues of transgenic mice. Genesis 35, 100-106 (2003).
38. Kolls, J.K. & Linden, A. Interleukin-17 family members and inflammation. Immunity 21, 467-476 (2004).
39. Ye, P. et al. Requirement of interleukin 17 receptor signaling for lung CXC chemokine and granulocyte colony-stimulating factor expression, neutrophil recruitment, and host defense. J. Exp. Med. 194, 519-527 (2001).
40. Kullberg, M.C. et al. IL-23 plays a key role in Helicobacter hepaticus-induced T cell-dependent colitis. J. Exp. Med. 203 2485-2494 (2006).
41. Shen, F., Hu, Z., Goswami, J. & Gaffen, S.L. Identification of common transcriptional regulatory elements in interleukin-17 target genes. J. Biol. Chem. 281, 24138-24148 (2006).
42. Sato, S. et al. Essential function for the kinase TAK1 in innate and adaptive immune responses. Nat. Immunol. 6, 1087-1095 (2005).
43. Shim, J.H. et al. TAK1, but not TAB1 or TAB2, plays an essential role in multiple signaling pathways in vivo. Genes Dev. 19, 2668-2681 (2005).
44. Park, H. et al. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat. Immunol. 6, 1133-1141 (2005).
45. Weaver, A. et al. An elevated matrix metal loproteinase (MMP) in an animal model of multiple sclerosis is protective by affecting Th1/Th2 polarization. FASEB J. 19, 1668-1670 (2005).
46. Becher, B., Bechmann, I. & Greter, M. Antigen presentation in autoimmunity and CNS inflammation: How T lymphocytes recognize the brain. J. Mol. Med. 84, 532-543 (2006).
47. Gold, R., Linington, C. & Lassmann, H. Understanding pathogenesis and therapy of multiple sclerosis via animal models: 70 years of merits and culprits in experimental autoimmune encephalomyelitis research. Brain 129, 1953-1971 (2006).
48. Koenders, M.I. et al. Interleukin-17 receptor deficiency results in impaired synovial expression of interfeukin-I and matrix metalloproteinases 3, 9, and 13 and prevents cartilage destruction during chronic reactivated streptococcal cell wall-induced arthritis. Arthritis Rheum. 52, 3239-3247 (2005).
49. Liang, L., Porter, E.M. & She, W.C. Constitutive expression of the B7h ligand for inducible costimulator on naive B cells is extinguished after activation by distinct B cell receptor and interleukin 4 receptor-mediated pathways and can be rescued by CD40 signaling. J. Exp. Med. 196, 97-108 (2002).
50. Park, H. et al. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat. Immunol. 6, 1133-1141 (2005).
51. Hjelmstrom, P., Juedes, A.E., Fjell, J. & Ruddle, N.H. B-cell-deficient mice develop experimental allergic encephalomyelitis with demyelination after myelin oligodendrocyte glycoprotein sensitization. J. Immunol. 161, 4480-4483 (1998).
52. Li, Q., Estepa, G., Memet, S., Israel, A. & Verma, I.M. Complete lack of NF-κB activity in IKK1 and IKK2 double-deficient mice: Additional defect in neurulation. Genes Dev. 14, 1729-1733 (2000).
53. Lomaga, M.A. et al. TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signaling. Genes Dev. 13 1015-1024 (1999).
54. Han, Y., Wang, J., Zhou, Z. & Ransohoff, R.M. TGFβ1 selectively up-regulates CCR1 expression in primary murine astrocytes. Glia 30, 1-10 (2000).
55. Kordula, T. et al. Oncostatin M and the interleukin-6 and soluble interleukin-6 receptor complex regulate α1-antichymotrypsin expression in human cortical astrocytes. J. Biol. Chem. 273, 4112-4118 (1998).